Seven Key Considerations with Rectal Cancer MRI
In a cum laude awarded presentation at the European Congress of Radiology (ECR), researchers discussed misconceptions and pertinent principles for magnetic resonance imaging (MRI) of patients with rectal cancer, ranging from the diagnosis of mucinous tumors to the impact of mesorectal fascia status for rectal cancer recurrence.
Should Dual-Source CT be the New Standard for ER CCTA Assessment of Acute Chest Pain?
Recently published research revealed that coronary computed tomography angiography (CCTA) exams performed with dual-source CT were completed 22 minutes faster and had a nearly 28 percent higher frequency of good or excellent image quality in comparison to CCTA exams performed with single-source CT devices.
In a video interview from the recent American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) Symposium, Brian Chapin, MD, discussed emerging research that demonstrated the ability of the positron emission tomography (PET) agent 18F-rhPSMA-7.3 to diagnose distant M1 lesions prior to surgery for patients with intermediate to high-risk prostate cancer.
New Study Shows Benefits of Prostate Artery Embolization for Men with an Enlarged Prostate
Prostate artery embolization led to a 32 percent reduction of the prostate gland and a 42 percent decrease in prostate-specific antigen (PSA) values one year after the procedure, according to new research presented recently at the Society of Interventional Radiology (SIR) Annual Scientific Meeting in Phoenix.
Can Ultrasound Renal Denervation be a Game-Changer for Reducing Blood Pressure?
Findings from three randomized trials of ultrasound renal denervation revealed a significant reduction in daytime ambulatory systolic blood pressure in patients with varying levels of hypertension.
Cancer Screenings and COVID-19: What a New Study Shows
New research from the American Cancer Society comparing pre-pandemic cancer screening prevalence to the second year of the COVID-19 pandemic in the United States showed a 1.1 million decrease in breast cancer screenings, a 4.4 million decrease in cervical cancer screening and a 600,000 decrease in prostate cancer screenings.
Mammography Screening Intervals and DCIS: What a New Study Reveals
In a new study involving over 900,000 women, researchers found the cumulative six-year risk of mammography screening-detected ductal carcinoma in situ (DCIS) increased with shorter screening intervals and age.
Current Perspectives on the BCLC Staging System for Hepatocellular Carcinoma
February 24th 2023Reviewing recent changes to the Barcelona Clinic Liver Cancer (BCLC) staging system for hepatocellular carcinoma and the potential impact for interventional radiologists, these authors discuss key updates including the subdivision of patients with intermediate stage disease and emerging literature on systemic agents for advanced disease.
AI/CT Combination for Assessing Pulmonary Embolism Severity Gets FDA Nod
Facilitating expedited assessment of pulmonary embolism severity, the emerging artificial intelligence (AI) tool Rapid RV/LV reportedly calculates the right ventricle/left ventricle (RV/LV) ratio within minutes of a computed tomography pulmonary angiogram (CTPA).
Can a New AI Tool Improve Detection of Incidental Pulmonary Embolism on CT?
Noting that only 25 percent of incidental emboli are identified in reporting of initial computed tomography (CT) exams, Avicenna.AI said the artificial intelligence (AI)-enabled CINA-iPE is geared toward detecting incidental pulmonary embolism (PE) on chest CT scans.
Is Follow-Up Pelvic CT Coverage Necessary for Patients Treated for Hepatocellular Carcinoma?
Noting that pelvic coverage can increase radiation dosing for liver computed tomography (CT) by 29 to 39 percent, researchers found low three-year cumulative rates of incidental pelvic tumors and isolated pelvic metastasis in follow-up liver CT imaging of over 1,100 people treated for hepatocellular carcinoma.
Overcoming Burnout in Radiology
In a recent video interview, radiologist Jonathon Lee, MD, shared insights from his experience on the insidious nature of burnout, emphasized the link between work-life balance and productivity, and discussed a recent partnership between the teleradiology service provider vRad and the behavioral health consultancy VITAL WorkLife to help promote well-being for vRad teleradiologists.
How Accurate is the CT Severity Score for Predicting COVID-19 Severity?
The computed tomography severity score (CTSS) has sensitivity rates of 85 percent for predicting the severity of COVID-19 and 77 percent for predicting COVID-19 related mortality, according to a newly published meta-analysis.
Recurrent Prostate Cancer and Low PSA Levels: Can an Emerging PSMA PET Agent Have an Impact?
Use of the prostate-specific membrane antigen (PSMA) positron emission tomography (PET) agent piflufolastat F 18 led to treatment plan changes in nearly 40 percent of men with recurrent prostate cancer and low prostate-specific antigen (PSA) levels, according to new research presented recently at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers (GU) Symposium in San Francisco.